Management of Maternal Tachycardia

Initial Assessment and Diagnostic Workup

The European Heart Journal recommends determining hemodynamic stability first, assessing for signs of hypotension, altered mental status, chest pain, or shortness of breath that would indicate need for immediate cardioversion 3, 1
A 12-lead ECG should be performed to document the rhythm, identify the specific type of tachycardia, and evaluate for pre-excitation patterns or structural abnormalities, as suggested by Praxis Medical Insights 2
An echocardiogram is essential to rule out structural heart disease in any pregnant patient with documented arrhythmia, according to Praxis Medical Insights 1, 2
Thyroid function tests should be conducted to exclude hyperthyroidism, which occurs in 10-25% of patients with atrial fibrillation and requires specific management, as stated in the European Heart Journal 4

The European Heart Journal and Praxis Medical Insights recommend performing immediate electrical cardioversion if the patient is hemodynamically unstable, as this is safe at all stages of pregnancy and takes priority over pharmacological therapy when the mother or fetus is compromised 4, 3, 1, 2
For hemodynamically stable patients, Praxis Medical Insights suggests attempting vagal maneuvers first, followed by IV adenosine if vagal maneuvers fail, and IV metoprolol if adenosine is ineffective 1, 2

For supraventricular tachycardia, Praxis Medical Insights recommends first-line prophylaxis with cardioselective beta-blockers or digoxin for rate control 1, 2
The European Heart Journal suggests that anticoagulation is mandatory for patients with atrial fibrillation, using therapeutic low-molecular-weight heparin at 24 weeks gestation, and avoiding warfarin in the first trimester due to teratogenicity 4, 1
For hyperthyroidism-related tachycardia, the European Heart Journal recommends beta-blockers to control ventricular rate while treating the underlying thyrotoxicosis, and calcium channel antagonists if beta-blockers are contraindicated 4

The European Heart Journal and Praxis Medical Insights advise that amiodarone should only be used when all other therapies have failed, and at the lowest effective dose, due to significant fetotoxic effects 3, 1

Praxis Medical Insights recommends referring to the emergency department or a higher level of care if there are recurrent episodes despite initial management, development of syncope or near-syncope, signs of hemodynamic instability, or sustained tachycardia causing maternal or fetal compromise 2, 3, 1
The European Heart Journal suggests escalating care if there is a heart rate persistently in the 150s despite treatment, as this can cause hypoperfusion to the fetus 3

Praxis Medical Insights recommends regular monitoring of maternal symptoms and fetal well-being throughout pregnancy, as well as repeat echocardiogram if symptoms worsen or if there's concern for tachycardia-induced cardiomyopathy 1, 2
The European Heart Journal advises increased vigilance in the postpartum period, particularly for patients with congenital long QT syndrome who have a higher risk of cardiac arrest postpartum 3